NDC 50090-1302

Atovaquone and Proguanil Hydrochloride

Atovaquone And Proguanil Hydrochloride

Atovaquone and Proguanil Hydrochloride is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Atovaquone; Proguanil Hydrochloride.

Product ID50090-1302_27774445-5d23-4b1b-ae29-f1e6c7ec9028
NDC50090-1302
Product TypeHuman Prescription Drug
Proprietary NameAtovaquone and Proguanil Hydrochloride
Generic NameAtovaquone And Proguanil Hydrochloride
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2011-09-15
Marketing CategoryANDA / ANDA
Application NumberANDA091211
Labeler NameA-S Medication Solutions
Substance NameATOVAQUONE; PROGUANIL HYDROCHLORIDE
Active Ingredient Strength250 mg/1; mg/1
Pharm ClassesAntimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50090-1302-0

7 TABLET, FILM COATED in 1 BOTTLE (50090-1302-0)
Marketing Start Date2014-11-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-1302-0 [50090130200]

Atovaquone and Proguanil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA091211
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28
Marketing End Date2019-11-30

NDC 50090-1302-2 [50090130202]

Atovaquone and Proguanil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA091211
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28
Marketing End Date2019-05-31

NDC 50090-1302-7 [50090130207]

Atovaquone and Proguanil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA091211
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28
Marketing End Date2019-05-31

NDC 50090-1302-9 [50090130209]

Atovaquone and Proguanil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA091211
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-09-28
Marketing End Date2019-05-31

NDC 50090-1302-5 [50090130205]

Atovaquone and Proguanil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA091211
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28

NDC 50090-1302-6 [50090130206]

Atovaquone and Proguanil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA091211
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28

NDC 50090-1302-3 [50090130203]

Atovaquone and Proguanil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA091211
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28

NDC 50090-1302-4 [50090130204]

Atovaquone and Proguanil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA091211
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28

NDC 50090-1302-8 [50090130208]

Atovaquone and Proguanil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA091211
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-09-29
Marketing End Date2019-05-31

NDC 50090-1302-1 [50090130201]

Atovaquone and Proguanil Hydrochloride TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA091211
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28
Marketing End Date2019-05-31

Drug Details

Active Ingredients

IngredientStrength
ATOVAQUONE250 mg/1

Pharmacological Class

  • Antimalarial [EPC]
  • Antiprotozoal [EPC]
  • Antimalarial [EPC]
  • Dihydrofolate Reductase Inhibitors [MoA]

NDC Crossover Matching brand name "Atovaquone and Proguanil Hydrochloride" or generic name "Atovaquone And Proguanil Hydrochloride"

NDCBrand NameGeneric Name
0378-4160Atovaquone and Proguanil Hydrochlorideatovaquone and proguanil hydrochloride
0378-4162Atovaquone and Proguanil Hydrochlorideatovaquone and proguanil hydrochloride
10544-909Atovaquone and Proguanil HydrochlorideAtovaquone and Proguanil Hydrochloride
33261-900Atovaquone and Proguanil HydrochlorideAtovaquone and Proguanil Hydrochloride
42254-150Atovaquone and Proguanil HydrochlorideAtovaquone and Proguanil Hydrochloride
43063-393Atovaquone and Proguanil HydrochlorideAtovaquone and Proguanil Hydrochloride
50090-1302Atovaquone and Proguanil HydrochlorideAtovaquone and Proguanil Hydrochloride
68001-245Atovaquone and Proguanil HydrochlorideAtovaquone and Proguanil Hydrochloride
68258-1104Atovaquone and Proguanil HydrochlorideAtovaquone and Proguanil Hydrochloride
68462-404Atovaquone and Proguanil HydrochlorideAtovaquone and Proguanil Hydrochloride
60760-498Atovaquone and Proguanil HydrochlorideAtovaquone and Proguanil Hydrochloride
63187-879Atovaquone and Proguanil HydrochlorideAtovaquone and Proguanil Hydrochloride
43063-522Atovaquone and Proguanil HClatovaquone and proguanil hydrochloride
50090-2980Atovaquone and Proguanil HClatovaquone and proguanil hydrochloride
0173-0675MALARONEatovaquone and proguanil hydrochloride
0173-0676MALARONEatovaquone and proguanil hydrochloride
50090-0687MALARONEatovaquone and proguanil hydrochloride
50090-0688MALARONEatovaquone and proguanil hydrochloride

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.